UBS Group
HIT

UBS Group’s Health In Tech Inc HIT Stock Holding History

UBS Group’s Portfolio HIT Stock Details HIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.28K Sell
5,223
-2,980
-36% -$3.7K ﹤0.01% 8945
2026
Q1 		$11.9K Sell
8,203
-395,953
-98% -$575K ﹤0.01% 8275
2025
Q4 		$643K Buy
404,156
+294,440
+268% +$643K ﹤0.01% 5928
2025
Q3 		$352K Sell
109,716
-17,059
-13% -$40.9K ﹤0.01% 6332
2025
Q2 		$112K Buy
126,775
+26,600
+27% +$17.7K ﹤0.01% 7144
2025
Q1 		$66.3K Buy
100,175
+97,839
+4,188% +$471K ﹤0.01% 7367
2024
Q4 		$12.5K Buy
+2,336
New +$12.5K ﹤0.01% 8192

Other funds holding HIT

WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

UBS Group's HIT Position: Q2 2026 in Review

UBS Group reduced its Health In Tech Inc (HIT) stake by 36% in Q2 2026, selling an estimated $3.7K and leaving 5,223 shares worth $5.28K. The position accounts for ﹤0.01% of the portfolio, ranked #8945.

UBS Group first reported a position in HIT in Q4 2024 and has held it in 7 quarters since. The position peaked at $643K in Q4 2025. 21 funds tracked by Wall St. Rank hold HIT as of Q2 2026.

  • UBS Group held 5,223 shares of Health In Tech Inc worth $5.28K as of Q2 2026.
  • UBS Group sold 2,980 Health In Tech Inc shares in Q2 2026, an estimated $3.7K.
  • Health In Tech Inc made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #8945 holding.
  • UBS Group first reported a position in Health In Tech Inc in Q4 2024 and has held it in 7 quarters since.
  • UBS Group's Health In Tech Inc position peaked at $643K in Q4 2025.
  • 21 funds tracked by Wall St. Rank held Health In Tech Inc as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.